Exhibit 99.2

Interim condensed consolidated financial statements of

Quantum eMotion Corp.

Three and six month periods ended June 30, 2026, and 2025

(Unaudited, in Canadian dollars)

QUANTUM eMOTION CORP.

Table of Contents

Quantum emotion Corp.

Interim Condensed Consolidated Statements of Financial Position

(Unaudited, in Canadian dollars)

See accompanying notes to interim condensed consolidated financial statements.

Approved on behalf of the Board:

Quantum emotion Corp.

Interim Condensed Consolidated Statements of Loss and Comprehensive Loss

(Unaudited, in Canadian dollars)

See accompanying notes to interim condensed consolidated financial statements.

Quantum emotion Corp.

Interim Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited, in Canadian dollars)

See accompanying notes to consolidated financial statements.

Quantum emotion Corp.

Interim condensed consolidated statements of Cash Flows

(Unaudited, in Canadian dollars)

See accompanying notes to interim condensed consolidated financial statements.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

1.             Nature of operations

Quantum eMotion Corp. (the “Company”) was incorporated under the Business Corporations Act of Ontario on July 19, 2007.

The head office, principal address and records office of the Company are located at 2300 Alfred Nobel, Montreal, QC, H4S 2A4. The Company is a developer of a new generation of quantum-based cryptographic solutions pursuant to the development of intellectual property and subsequent commercialization of cybersecurity solutions.

These interim condensed consolidated financial statements have been prepared by management in accordance with IAS 34 Interim financial reporting and using the same accounting policies and methods of computation as those used in preparing the audited annual consolidated financial statements for the year ended December 31, 2025. The unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited annual consolidated financial statements and accompanying notes for the year ended December 31, 2025, which have been prepared in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

The Board of Directors approved and authorized for issue these interim condensed consolidated financial statements on August 14, 2026.

Business combinations and asset acquisition

The Company determines that it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the ability to continue producing outputs.

Where the acquisition does not constitute a business, the Company uses the optional concentration of fair value test as outlined in IFRS 3. Under this test, if the fair value of the business acquired is concentrated in a single identifiable asset, the Company considers the acquisition to be an asset acquisition and not a business combination and measures the asset at the purchase price.

Any contingent consideration to be transferred by the acquirer will be recognized at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IFRS 9 Financial Instruments, is measured at fair value in accordance with IFRS 13 with the changes in fair value recognized in the statement of profit or loss in accordance with IFRS 9.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

3.             Investments (Cont’d)  

The Company designated the investments shown above as equity securities at FVOCI because these equity securities represent investments that the Company intends to hold for the long-term for strategic purposes. No strategic investments were disposed of during the period and there were no transfers of any cumulative gain or loss within equity relating to these investments. 

Acquisition of SKV Technology Inc.

On April 2, 2026, the Corporation acquired 100% of the issued and outstanding shares of SKV, a California-based entity which holds legal title to the SecureKey™ technology, a cryptographic software solution (the “SKV Acquisition”).

Consideration Amount and Range of Outcomes

No cash, Common Shares, or other consideration was paid at closing. The consideration for the SKV Acquisition consists entirely of contingent payments structured as follows: up to C$7,000,000 in milestones-based earn-out payments and up to C$15,000,000 in royalty payments.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

The contractual range of undiscounted contingent consideration payments is from $Nil to a maximum of C$22,000,000, consisting of up to C$7,000,000 in milestone payments and up to C$15,000,000 in royalties. As at June 30, 2026, the first two milestones have been achieved resulting in a payment of C$1,500,000.

The milestone payments are tied to specific technical and commercial achievements. The royalty payments are based on cumulative sales of products incorporating the SecureKey technology over a five-year period. Achieving the maximum royalty amount of C$15,000,000 would require cumulative sales of approximately C$195,000,000 over the five-year royalty period.

Basis for Determining Consideration Amount

The consideration was negotiated at arm's length and reflects the Corporation’s assessment of the potential strategic value and expected synergies from integrating the SecureKey intellectual property with the Corporation’s existing assets and platforms. The assessment considered, among other factors: (i) the nature and scope of the intellectual property rights acquired; (ii) the existence of technical documentation supporting the technology and its readiness for integration, including documentation relevant to certification and validation efforts; (iii) the alignment of the SecureKey technology with the Corporation’s strategic initiatives; and (iv) current and expected market demand for cryptographic protection.

The Corporation’s evaluation indicated that developing equivalent technology internally would require significant development time, resource commitment, and would carry material technological and financial risks.

The contingent consideration structure was established to mitigate the risk of overpayment by linking payments to the achievement of specified technical and commercial outcomes. The Corporation will pay the maximum royalty amount only if aggregate sales over the five-year royalty period reach substantial levels.

Relationships Between the Corporation and Sellers

The transaction was conducted at arm’s length. No directors, officers, or insiders of the Corporation were involved as sellers or otherwise had an interest in the transaction. The Corporation engaged Jason Thomas, one of the sellers and founder of SKV, as an employee of the Corporation concurrently with the closing of the SKV Acquisition.

Stage of Development of Acquired Technology

The SecureKey technology is a cryptographic software solution designed to provide securitization of latent data. The technology includes associated certification-related work product completed prior to the SKV Acquisition and documentation prepared to support validation under the NIST FIPS framework applicable to cryptographic technology.

The technology has been functionally tested and validated by the developers. Technical documentation and source code were transferred to the Corporation, enabling the Corporation to commence integration work immediately following closing. The technology has been integrated into the Corporation's product offerings.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

Accounting Treatment

The transaction has been accounted for as an asset acquisition under IFRS 3. At the acquisition date, the Corporation recognized an intangible asset representing the acquired intellectual property and a corresponding contingent consideration liability of $10,085,274 representing the fair value of the potential future milestone and royalty payments. The intangible asset will be amortized over five years on a straight-line basis. The fair value was determined using an income approach (a discounted present value technique based on probability-weighted expected future payments), reflecting market participant assumptions regarding the probability of achieving the commercialization milestones and projected future sales, as well as the expected timing of payments over several years using a discount rate of 30%.

As stated above, the Company recognized an initial value for the contingent liability to be $10,085,274. The first two milestones, with a combined earn-out value of $1.5 million, were paid and recorded against contingent liability in the second quarter. In addition, the Company performed a fair value assessment of this liability as of June 30, 2026, and calculated a fair-value adjustment using the discounted cash flow method with a 30% discount factor of $423,798 which was expensed in the second quarter. The remaining balance of contingent liability as at June 30, 2026, is $9,009,072.

Milestone payments are contingent upon the achievement of specified technical and commercial milestones, the timing of which is uncertain and dependent on the Corporation’s development progress and market conditions. Royalty payments are expected to occur over a five-year period following the date of the first sale, contingent upon sales of products incorporating the SecureKey technology.

Significant uncertainties

The fair value measurement reflected the expected timing of payments over several years. Uncertainties exist regarding both the amount and timing of future outflows, including:

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

The fair value measurement of the contingent consideration was based on the following major assumptions:

5.            Right-of-use asset

6.             Lease liability

The Company signed a three-year lease for its location at Temecula, California on May 1, 2026.

The lease ends on April 30, 2029.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

7.            Tax credits receivable

As at June 30, 2026, the Company had accounts receivable of $4,954, interest receivable of $20,260 and sales taxes receivable of $222,852 bringing the total of accounts and taxes receivable to $550,444.

8.            Grants receivable

The Company received confirmation from the National Sciences and Engineering Research Council of Canada (NSERC) that the Company was awarded funding of up to $600,000 in support of a research and development project focused on quantum-secure semiconductor technology in collaboration with JMEM Tek. The Company received payment of $101,084 for claims made in the first quarter of 2026 and claimed $64,621 in the second quarter of 2026.

9.             Share capital

The Company is authorized to issue an unlimited number of:

without nominal or par value.

Class A preferred shares are ranked senior to Class B preferred shares, Class B preferred shares are ranked senior to Class C preferred shares, Class C preferred shares are ranked senior to Class D preferred shares, Class D preferred shares are ranked senior to special shares, and special shares are ranked senior to common shares in priority of receiving dividends declared by the Company.

Holders of special shares and common shares shall be entitled to receive pro-rata for the remaining property of the Company after distribution to the holders of Class A, Class B, Class C and Class D preferred shares, on a pro-rata basis.

Dividends for Class A, Class B, Class C and Class D preferred shares are preferential and non-cumulative and are declared in accordance with their respective priority. Dividend rate per share for Class B, Class C and Class D preferred shares is 7% per annum. Dividends are declared at the discretion of the Company’s Board of Directors.

Quantum emotion Corp. 

Notes to the interim condensed consolidated financial statements 

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

9.             Share capital (cont’d)

(b)  Issued and outstanding

On June 2, 2025, the Company completed a brokered LIFE financing, issuing a total of 8,000,000 units at a price of $1.50 per unit for gross proceeds of $12,000,000. Each unit is comprised of one common share and one warrant of the Company. Each warrant entitles its holder to acquire one common share of the Company at a price of $1.82 for a period of 3 years following the closing of the date of issuance. There is no hold period for trading the warrants.

Unit issuance costs of $857,178, which include a broker fee of 6.0% as well as legal and listing costs, were recorded in the second quarter of 2025. In addition, the Company issued 320,000 warrants representing 4% of the units issued to the Agent that brokered the private placement. Each warrant entitles its holder to acquire one common share of the Company at a price of $1.66 for a period of 2.5 years following the closing of the date of issuance. There is no hold period for trading the warrants.

On February 24, 2025, the Company completed a brokered LIFE financing, issuing a total of 13,333,333 units at a price of $0.75 per unit for gross proceeds of $10,000,000. Each unit is comprised of one common share and one warrant of the Company. Each warrant entitles its holder to acquire one common share of the Company at a price of $1.10 for a period of 3 years following the closing of the date of issuance. There is no hold period for trading the warrants.

Unit issuance costs of $811,413, which include a broker fee of 6.5% as well as legal and listing costs, were recorded in the first quarter of 2025. In addition, the Company issued 666,666 warrants representing 5% of the issued units to the Agent that brokered the private placement. Each warrant entitles its holder to acquire one common share of the Company at a price of $0.88 for a period of 2.5 years following the closing of the date of issuance. There is no hold period for trading the warrants.

Common shares and warrants were valued based on their relative fair values. The fair value of the common shares was determined by the closing price on the date of the transaction. The fair value of the warrants was determined using the Black-Scholes pricing model and based on the following assumptions:

As at June 30, 2026, no dividends were declared or unpaid (December 31, 2025 – $Nil).

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

9.             Share capital (cont’d)

(c)  Stock options

The Company's share options are as follows for the reporting periods presented:

Shareholders approved an amendment to convert the Company’s stock option plan pool to a rolling plan reserving a number of common shares equal to up to 10% of the Corporation’s issued and outstanding common shares as of the grant date of each option and to add a cashless exercise feature at the Company’s Annual General Meeting held on June 18, 2026. These changes were approved by the TSX Venture Exchange.

The weighted average share price at date of exercise for options exercised during the 3-month and 6-month periods respectively was $4.51 (June 30, 2025, and $4.61 and June 30, 2025 - $0.76).

The weighted average remaining contractual life for options outstanding on June 30, 2026, is 7.43 years (June 30, 2025 – 6.44 years).

Non-cash share-based compensation recognized under the plan amounted to $1,924,763 and $3,991,153 for the three-month and six-month periods ending June 30, 2026 (2025 – $560,272 and $3,126,265). Share-based compensation is provided to officers, employees and consultants and related to general and administrative expenses.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

9.             Share capital (cont’d)

The Company’s warrant movement for the six-month period ended June 30, 2026, (June 30, 2025, 25,618,322 at an average weighted price of $1.14) is as follows:

10.          Related party transactions

The Company’s related parties include companies owned by key management. The Company paid management fees to key management through their management companies as follows up to June 30, 2026:

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025

(Unaudited, in Canadian dollars)

10.           Related party transactions (cont’d)

Larry Moore did not seek re-election as director of the Company at the latest AGM on June 18, 2026.

Transactions with key management

The key management of the Company are the members of senior management and the Board. The remuneration and other expenses for the period of key management (including the amounts above) is as follows:

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

11.           Net financial (income) expense

The Company included the cost of the fair-value adjustment relating to the contingent liability as a financial expense in the second quarter.

12.           Financial instruments and risk management

The capital structure of the Company consists of equity attributable to shareholders, comprising issued share capital, contributed surplus and deficit. The Company’s objectives when managing capital are to: (i) preserve capital; (ii) obtain the best available net return; and (iii) maintain liquidity.

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares. There were no changes to the Company’s approach to capital management during the period ended June 30, 2026.

The classification of financial instruments as well as their carrying amounts are presented in the table below:

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

12.          Financial instruments and risk management (cont’d)

¹ Excludes taxes receivable, as these amounts do not represent a contractual right to receive cash or another financial asset.

Financial assets at FVOCI are presented in accordance with the fair value hierarchy. This hierarchy groups financial assets and liabilities into three levels based on the significance of inputs used in measuring the fair value of the financial assets and liabilities as defined in note 3. The level within which the financial asset or liability is classified is determined based on the lowest level of significant input to the fair value measurement. The fair value of the investments classified as FVOCI (note 3), is measured under level 3 of the fair value hierarchy. There have been no transfers between levels in the reporting periods.

The fair value of investments not quoted in an active market may be determined by the Company using reputable pricing sources or indicative prices from bond/debt market makers. The Company would exercise judgment and estimates on the quantity and quality of pricing sources used. Where no market data is available, the Company might value positions using its own models, which are usually based on valuation methods and techniques generally recognized as standard within the industry. The inputs into these models are primarily adjusted market data and discounted cash flows. The models used to determine fair values are validated and periodically reviewed by experienced personnel at the Company, independent of the party that created them.

The models used for private equity securities are based mainly on observable transaction data or discounted future cash flows, adjusted for lack of marketability and control premiums. The models used for debt securities are based on the net present value of estimated future cash flows, adjusted as appropriate for liquidity, and credit and market risk factors.

Models use observable data, to the extent practicable. However, areas such as credit risk (both own and counterparty), volatilities and correlations require management to make estimates. Changes in assumptions about these factors could affect the reported fair value of financial instruments. The sensitivity to unobservable inputs is based on management’s expectation of reasonably possible shifts in these inputs, taking into consideration historical volatility and estimations of future market movements. The determination of what constitutes ‘observable’ requires significant judgment by the Company. The Company considers observable data to be market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

12.          Financial instruments and risk management (cont’d)

The following table provides information on the valuation techniques and the inputs used.

Quantum emotion Corp.

Notes to the interim condensed consolidated financial statements

Periods ended June 30, 2026, and 2025
(Unaudited, in Canadian dollars)

12.          Financial instruments and risk management (cont’d)

¹ Based on the terms of the investments, management assessed the initial fair value of the securities at $700,000 based on previous financing rounds conducted at arm’s length. However, since fair value is based on unobservable entity-specific inputs, the initial valuation was restricted to the transaction price determined to be $350,000, resulting in a deferred amount of $350,000, of which $59,760 is still deferred as of June 30, 2026. Management policy is to recognize in profit or loss the difference between the fair value at initial recognition and the transaction price based on subsequent financing rounds.